Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer
Clinical trial NCT03894007 · TERMINATED
Trial details
- NCT number
- NCT03894007
- Sponsor
- Renske Altena
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2021-06-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.